Prognostic significance of young age (<35 Years) by subtype based on ER, PR, and HER2 status in breast cancer: A nationwide registry-based study

World Journal of Surgery

Volumn 35, Issue 6, 2011, Pages 1244-1253

  Kim, Eun Kyu ^a   Noh, Woo Chul ^a   Han, Wonshik ^b   Noh, Dong Young ^b  

^a Korea Cancer Center Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGE; ARTICLE; BREAST TUMOR; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FACTUAL DATABASE; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; KOREA; MASTECTOMY; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; SURVIVAL;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CAUSE OF DEATH; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KOREA; MASTECTOMY; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79956000523     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1071-1     Document Type: Article

References (32)

1. DP Winchester RT Osteen HR Menck 1996 The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age Cancer 78 8 1838 1843 8859200 10.1002/(SICI)1097-0142(19961015)78:8<1838::AID- CNCR27>3.0.CO;2-Y 1:STN:280:DyaK2s%2Fht1ertw%3D%3D (Pubitemid 26330915)
2. M Chung HR Chang KI Bland, et al. 1996 Younger women with breast carcinoma have a poorer prognosis than older women Cancer 77 97 103 8630946 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3 1:STN:280:DyaK283itlegtQ%3D%3D (Pubitemid 26002742)
3. W Han SW Kim IA Park, et al. 2004 Young age: an independent risk factor for disease-free survival in women with operable breast cancer BMC Cancer 4 82 15546499 10.1186/1471-2407-4-82 (Pubitemid 40180272)
4. SH Ahn BH Son SW Kim, et al. 2007 Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea-a report from the Korean Breast Cancer Society J Clin Oncol 25 17 2360 2368 17515570 10.1200/JCO.2006.10.3754 (Pubitemid 47007614)
5. RA Walker E Lees MB Webb, et al. 1996 Breast carcinomas occurring in young women (<35 years) are different Br J Cancer 74 11 1796 1800 8956795 10.1038/bjc.1996.632 1:STN:280:DyaK2s7hsFeqtg%3D%3D (Pubitemid 26401901)
6. M Colleoni N Rotmensz C Robertson, et al. 2002 Very young women (<35 years) with operable breast cancer: features of disease at presentation Ann Oncol 13 2 273 279 11886005 10.1093/annonc/mdf039 1:STN:280: DC%2BD387ltl2gtw%3D%3D
7. AJ Nixon D Neuberg DF Hayes, et al. 1994 Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer J Clin Oncol 12 5 888 894 8164038 1:STN:280:DyaK2c3hs12gtA%3D%3D (Pubitemid 24145313)
8. S Aebi S Gelber M Castiglione-Gertsch, et al. 2000 Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355 9218 1869 1874 10866443 10.1016/S0140-6736(00)02292-3 1:CAS:528: DC%2BD3cXkt1Crsbs%3D (Pubitemid 30311879)
9. A Goldhirsch RD Gelber G Yothers, et al. 2001 Adjuvant therapy for very young women with breast cancer: need for tailored treatments J Natl Cancer Inst Monogr 30 44 51 11773291
10. T Sorlie CM Perou R Tibshirani, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 19 10869 10874 11553815 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D (Pubitemid 32878711)
11. T Sorlie R Tibshirani J Parker, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 14 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528: DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
12. LJ van t'Veer H Dai MJ van de Vijver, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 530 536 10.1038/415530a (Pubitemid 34130608)
13. C Sotiriou SY Neo LM McShane, et al. 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 18 10393 10398 12917485 10.1073/pnas.1732912100 1:CAS:528:DC%2BD3sXntFynsrk%3D (Pubitemid 37071889)
14. LA Carey CM Perou CA Livasy, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 21 2492 2502 16757721 10.1001/jama.295.21.2492 1:CAS:528:DC%2BD28XlsV2rtLw%3D (Pubitemid 43854964)
15. JD Brenton LA Carey AA Ahmed, et al. 2005 Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 29 7350 7360 16145060 10.1200/JCO.2005.03.3845 1:CAS:528: DC%2BD2MXhtF2nsLrJ (Pubitemid 46202348)
16. Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York
17. YO Ahn 2007 Cancer registration in Korea: The present and furtherance J Prev Med Public Health 40 4 265 272 17693728 10.3961/jpmph.2007.40.4.265
18. HR Shin 2008 Global activity of cancer registries and cancer control and cancer incidence statistics in Korea J Prev Med Public Health 41 2 84 91 18385548 10.3961/jpmph.2008.41.2.84
19. W Han SY Kang 2010 Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer Breast Cancer Res Treat 119 1 193 200 19350387 10.1007/s10549-009-0388-z
20. Ries LAG, Melbert D, Krapcho M et al (2009) SEER Cancer Statistics Review 1975-2006, National Cancer Institute, Bethesda, MD. Available at http://seer.cancer.gov/csr/1975-2006/. Accessed 19 April 2010
21. SS Ko 2008 Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update J Surg Oncol 98 5 318 323 18623175 10.1002/jso.21110
22. Y Minami Y Tsubono Y Nishino, et al. 2004 The increase of female breast cancer incidence in Japan: emergence of birth cohort effect Int J Cancer 108 6 901 906 14712495 10.1002/ijc.11661 1:CAS:528:DC%2BD2cXht1CitLk%3D (Pubitemid 38112621)
23. L Yang DM Parkin J Ferlay, et al. 2005 Estimates of cancer incidence in China for 2000 and projections for 2005 Cancer Epidemiol Biomarkers Prev 14 1 243 250 15668501 (Pubitemid 40165308)
24. YC Shen CJ Chang C Hsu, et al. 2005 Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis Cancer Epidemiol Biomarkers Prev 14 8 1986 1990 16103449 10.1158/1055-9965.EPI-04-0932 (Pubitemid 41161212)
25. EA Rakha ME El-Sayed AR Green, et al. 2007 Prognostic markers in triple-negative breast cancer Cancer 109 1 25 32 17146782 10.1002/cncr.22381 1:CAS:528:DC%2BD2sXhtVKrtLY%3D (Pubitemid 46120191)
26. KR Bauer M Brown RD Cress, et al. 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 9 1721 1728 17387718 10.1002/cncr.22618 (Pubitemid 46668532)
27. CU Ihemelandu LD Leffall Jr RL Dewitty, et al. 2007 Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome Ann Surg Oncol 14 10 2994 3003 17647064 10.1245/s10434-007-9477-6 (Pubitemid 47460642)
28. PL Nguyen AG Taghian MS Katz, et al. 2008 Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 14 2373 2378 18413639 10.1200/JCO.2007.14.4287
29. BG Haffty Q Yang M Reiss, et al. 2006 Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 36 5652 5657 17116942 10.1200/JCO.2006.06.5664 (Pubitemid 46631305)
30. A Goldhirsch WC Wood RD Gelber, et al. 2003 Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer J Clin Oncol 21 17 3357 3365 12847142 10.1200/JCO.2003.04.576 (Pubitemid 46606270)
31. A Goldhirsch JH Glick RD Gelber, et al. 2005 Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 10 1569 1583 16148022 10.1093/annonc/mdi326 1:STN:280:DC%2BD2MvpvFKhsA%3D%3D (Pubitemid 41511089)
32. A Goldhirsch WC Wood RD Gelber, et al. 2007 Progress, promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 7 1133 1144 17675394 10.1093/annonc/mdm271 1:STN:280:DC%2BD2svlvVSkuw%3D%3D (Pubitemid 47244357)